Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Measurable Residual Disease in Extracellular Vesicles from Bone Marrow and Peripheral Blood of Patients with Multiple Myeloma: A Proof-of-Concept Study

Rui Bergantim, Mélanie A.G. Barbosa, Sara Peixoto da Silva, Bárbara Polónia, Hugo R. Caires, José E. Guimarães, M. Helena Vasconcelos

Blood (2021) 138 (Supplement 1): 4712.

https://doi.org/10.1182/blood-2021-149398

Published: 2021

Journal Articles

Mir-128 and DNA Damage In Acute Myeloid Leukemia

Hugo Seca, Raquel T. Lima, Gabriela M. Almeida, Manuel Sobrinho-Simões, Rui Bergantim, Jose E. Guimaraes, MD, PhD, M. Helena Vasconcelos

Blood (2013) 122 (21): 2533.

https://doi.org/10.1182/blood.V122.21.2533.2533

Published: 2013

Journal Articles

Antimir-21 Causes Autophagy in the K562 Cell Line and Sensitizes Cells to the Effect of Doxorubicin and Etoposide

Hugo Seca, Raquel T. Lima, Vanessa Lopes-Rodrigues, Jose E. Guimaraes, MD, PhD, Gabriela M. Almeida, M. Helena Vasconcelos

Blood (2012) 120 (21): 4908.

https://doi.org/10.1182/blood.V120.21.4908.4908

Published: 2012

Journal Articles

Targeting XIAP for Chemosensitization Purposes: Different Effect with Different Cytotoxic Drugs.

Hugo Seca, BSc, MSc, Liliana Santos, BSc, Joana Figueiredo, BSc, Raquel T. Lima, BSc, MSc, Jose E. Guimaraes, MD, PhD, Clara Sambade, MD, PhD, M. Helena Vasconcelos, BSc, MSc, PhD

Blood (2008) 112 (11): 1597.

https://doi.org/10.1182/blood.V112.11.1597.1597

Published: 2008

Journal Articles

Evaluation of XIAP as a Molecular Target To Increase Sensitivity to Imatinib.

Hugo Seca, BSc, Raquel T. Lima, MSc, BSc, Jose E. Guimaraes, PhD, MD, M. Helena Vasconcelos, PhD, MSc, BSc

Blood (2006) 108 (11): 1381.

https://doi.org/10.1182/blood.V108.11.1381.1381

Published: 2006

Journal Articles

Overcoming Resistance to Imatinib Mesylate in a CML Cell Line by Downregulation of P-gp with siRNAs.

Raquel T. Lima, BSc, Jose E. Guimaraes, MD, PhD, M. Helena Vasconcelos, BSc, MSc, PhD

Blood (2005) 106 (11): 1526.

https://doi.org/10.1182/blood.V106.11.1526.1526

Published: 2005

NARROW

Measurable Residual Disease in Extracellular Vesicles from Bone Marrow and Peripheral Blood of Patients with Multiple Myeloma: A Proof-of-Concept Study

Mir-128 and DNA Damage In Acute Myeloid Leukemia

Antimir-21 Causes Autophagy in the K562 Cell Line and Sensitizes Cells to the Effect of Doxorubicin and Etoposide

Targeting XIAP for Chemosensitization Purposes: Different Effect with Different Cytotoxic Drugs.

Evaluation of XIAP as a Molecular Target To Increase Sensitivity to Imatinib.

Overcoming Resistance to Imatinib Mesylate in a CML Cell Line by Downregulation of P-gp with siRNAs.

Email alerts

ASH Publications

American Society of Hematology

Measurable Residual Disease in Extracellular Vesicles from Bone Marrow and Peripheral Blood of Patients with Multiple Myeloma: A Proof-of-Concept Study

Mir-128 and DNA Damage In Acute Myeloid Leukemia

Antimir-21 Causes Autophagy in the K562 Cell Line and Sensitizes Cells to the Effect of Doxorubicin and Etoposide

Targeting XIAP for Chemosensitization Purposes: Different Effect with Different Cytotoxic Drugs.

Evaluation of XIAP as a Molecular Target To Increase Sensitivity to Imatinib.

Overcoming Resistance to Imatinib Mesylate in a CML Cell Line by Downregulation of P-gp with siRNAs.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only